We examined the prevalence of use and cost impact of DPP-4 inhibitors and GLP-1 receptor agonists in people with diabetes.
Brandeis Seymore, RPh
Advertisement
Articles by Brandeis Seymore, RPh
Advertisement
Latest Updated Articles
- The Expanding Role of New Medications in the Treatment of Type 2 Diabetes Mellitus
Published: August 21st 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Final EMBARK Data Show “Almost Unprecedented” Reduction in Risk of Death With Enzalutamide Plus ADT in Biochemically Recurrent Prostate Cancer
2
Dato-DXd Doubles Response Rates and Extends Survival in First-Line Metastatic TNBC
3
Weekly Paclitaxel May Hold the Key to Pembrolizumab’s Success in Platinum-Resistance Ovarian Cancer
4
From Mutation to Medicine: Targeted Therapies in Lung Cancer
5
